HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
DNAPrint(TM) genomics, Inc. Agrees to Acquire Majority Ownership in German Pharmaceutical Company Biofrontera AG; Secures $35 Million Equity Commitment from Dutchess Private Equities Fund, L.P.
-
PR Newswire; Sep 28, 2004; 700+ Words
...German pharmaceutical company Biofrontera AG. DNAPrint simultaneously announced...placebo in clinical symptoms. Biofrontera has also advanced a novel prophylactic...Doctor Hermann Luebbert, CEO of Biofrontera AG, will join the DNAPrint board...
-
-
Appointments at Biofrontera AG.(Biofrontera Pharmaceuticals GmbH appointed Werner Pehlemann )(Brief Article)
-
Pharma Marketletter; Feb 6, 2006; 507 Words
German dermatological drugs development company Biofrontera AG has appointed Werner Pehlemann as chief financial officer and has named Reinhold Gahlmann as managing director of its Biofrontera Bioscience GmbH subsidiary, which undertakes the group's R&D activities.
-
-
Biofrontera AG-Company Report.
-
M2 Presswire; Feb 4, 2009; 494 Words
...4 February 2009-www.companiesandmarkets.com: Biofrontera AG-Company Report(C)1994-2009 M2 COMMUNICATIONS...www.companiesandmarkets.com adds new report: Biofrontera AG-Company Report Private Company Reports provide up...
-
-
Biofrontera Strengthens Its Dermatology Drug Pipeline By Acquiring a Phase II Compound.
-
PR Newswire; Oct 7, 2004; 700+ Words
...Germany, Oct. 7 /PRNewswire/ -- Biofrontera AG today announced that it has acquired...Prof. Dr. Lubbert, CEO of Biofrontera AG, commented: "We are delighted...product to the market." About Biofrontera AG Biofrontera is aiming to become...
-
-
Biofrontera wins grant
-
Pharmaceutical Technology Europe; Apr 1, 2004; ; 327 Words
...help us to advance important research projects," commented Hermann Lubbert, CEO of Biofrontera AG. Biofrontera is a wholly-owned subsidiary of Biofrontera AG, a neuroscience company based on natural compound discovery. @www.biofrontera...
-
-
DISCOVERY ACQUIRES BIOFRONTERA, EXPECTS TO LOSE MONEY IN 2005.
-
BIOWORLD Today; Mar 2, 2005; ; 700+ Words
...Heidelberg, Germany-based Biofrontera Discovery GmbH, the natural...discovery division of privately held Biofrontera AG. "We realized the market for...clinical development. "The Biofrontera acquisition is the first step...
-
-
Discovery Partners International Announce Signing of Binding Letter of Intent to Acquire Biofrontera Discovery GmbH.
-
PR Newswire; Mar 1, 2005; 700+ Words
...confirmatory due diligence, to acquire Biofrontera Discovery GmbH, based in Heidelberg...drug discovery subsidiary of Biofrontera AG, a privately held specialty...business. With the acquisition of Biofrontera Discovery, which will be managed...
-
-
German Biofrontera completes capital increase.
-
ADP News Germany; Sep 9, 2009; 372 Words
...ADPnews) - Sep 9, 2009 - German biotechnology firm Biofrontera AG (ETR:B8F) has successfully completed a capital...base capital will increase to EUR 7.34 million. Biofrontera will use the proceeds from the capital hike to reach...
-
-
Biofrontera Pharmaceuticals and Janssen Pharmaceutica Enter a Research Agreement to Explore Modulation of Nicotinic Receptors in Treatment of Alzheimer's Disease.
-
Business Wire; Aug 27, 2001; 700+ Words
...between Janssen Pharmaceutica NV and Biofrontera Pharmaceuticals AG to explore the potential benefits of...stroke, and Parkinson's disease. Biofrontera Pharmaceuticals AG (www.biofrontera.de) is a research-enabled drug discovery...
-
-
Biofrontera expands dermatology pipeline.(Brief Article)
-
Pharma Marketletter; Oct 18, 2004; 567 Words
Biofrontera AG of Germany has acquired from ASAT AG of Switzerland all intellectual...for the treatment of basal cell carcinomas and actinic keratosis, says Biofrontera. With two dermatology products in advanced clinical development, both...
-
-
German Biofrontera launches medical cosmetic product Belixos.
-
ADP News Germany; Oct 8, 2009; 431 Words
...2009 - German biotechnology firm Biofrontera AG (ETR:B8F) unveiled today...proprietary biocolloid formulation, Biofrontera said. "This market launch represents...CEO Hermann Luebbert said. Biofrontera specialises in the development...
-
-
Discovery Partners to buy Biofrontera.(Pharmaceutical industry)(Brief Article)
-
Pharma Marketletter; Mar 14, 2005; 648 Words
...products drug discovery subsidiary of Biofrontera AG, for an undisclosed amount. The acquisition of Biofrontera Discovery will be managed under the...went on to say that "the addition of Biofrontera Discovery will allow current and future...
-
-
Evotec OAI and Biofrontera to Offer Natural Compounds for Drug Discovery Services.
-
PR Newswire; Oct 14, 2003; 684 Words
Evotec OAI AG (Deutsche Borse: EVT, TecDax 30) and Biofrontera Pharmaceuticals Holding AG today announced the signing of a co-marketing...services. For high-throughput screening Biofrontera utilises a unique collection of microorganisms...
-
-
Biofrontera Pharmaceuticals GmbH Raises DM 23 Million in Private Placement.
-
PR Newswire; May 31, 2000; 700+ Words
...May 31 /PRNewswire/ -- Biofrontera Pharmaceuticals GmbH, Leverkusen...KG (Munich), TRE Holding AG (Zurich), tbg Technologie...Kapitalbeteiligungsgesellschaft Koeln mbH. In 1998, Biofrontera Pharmaceuticals GmbH had already...Lubbert, CEO and founder of Biofrontera Pharmaceuticals GmbH. "Our...
-
-
BIOFRONTERA PHARMACEUTICALS GMBH RAISES DM 23 MILLION IN PRIVATE PLACEMENT.
-
PR Newswire; May 31, 2000; 605 Words
...transmitted on behalf of Biofrontera Pharmaceuticals GmbH Leverkusen, Germany - Biofrontera Pharmaceuticals GmbH...Munich), TRE Holding AG (Zurich), tbg Technologie...Kapitalbeteiligungsgesellschaft Koln mbH. In 1998, Biofrontera Pharmaceuticals GmbH had...
-
-
Pharmaceutical firm secures an investment of EUR 20 million by DNAPrint.
-
Science Letter; Nov 2, 2004; 700+ Words
...NewsRx.com & NewsRx.net) -- Biofrontera AG announced that the basis for future joint...of the six supervisory board seats at Biofrontera, and Prof. Hermann Lubbert, CEO of Biofrontera AG, will join the DNAPrint board of directors...
-
-
DNAPrint Announces German Business Partner's Progress in Clinical Trial for BF-200.
-
M2 Presswire; Jan 25, 2007; 700+ Words
...announced that its German business partner, Biofrontera AG (Frankfurt:B8F.F), in which the Company...5 million new cases per year in Europe. About Biofrontera AG Biofrontera AG is specialized in the development of pharmaceutical...
-
-
DNAPrint genomics Acquires 18% Stake in German Company.
-
PR Newswire; Jul 13, 2005; 700+ Words
...has acquired an 18% stake in Biofrontera AG of Leverkusen, Germany, for...Hector Gomez, remained on the Biofrontera Board of Directors. "Our relationship...We believe the acquisition of Biofrontera AG shares and our presence on the...
-
-
Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT.
-
PR Newswire; Jun 23, 2008; 700+ Words
...being. Recent Developments Biofrontera AG of Germany, listed on Frankfurt...approxiametely $175,000 in Biofrontera shares will augment revenues...strategic business association with Biofrontera AG is an important extension of...
-
-
DNAPrint genomics to acquire majority ownership in German pharmaceutical company.
-
Immunotherapy Weekly; Nov 3, 2004; 646 Words
...German pharmaceutical company Biofrontera, AG. DNAPrint simultaneously announced...00 million over 24 months in Biofrontera series B preferred shares (68...a 51.77% equity interest. Biofrontera will use the proceeds of the...
|
|